הכנסות שנתיות של החברה ProPhase Labs (PRPH)

ProPhase Labs, Inc. (PRPH) is implementing robotic PCR analysis systems to accelerate testing and is collaborating with clinics in the field of genetics. This product implementation chart demonstrates liquid demand, with the latest mark standing at 0.00. Amid saturation of the core market, the company is pivoting toward promising genomics and early oncology detection to attract new clients.

ProPhase Labs, Inc. (PRPH) sales reflect actual daily revenue from product realization, capturing the real scale of operational activity. Daily calculations allow for the immediate verification of the issuer's liquidity, uncovering hidden growth slowdowns hidden behind stable figures. By analyzing the volume of the company's realized products, an investor assesses the effectiveness of commercial expansion. For ProPhase Labs, Inc. (PRPH), this indicator confirms the synergy derived from laboratory acquisitions and the implementation of DNA testing within pharmacy chains.